person

Gaël N.

Country
France
Department
Génétique médicale

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 10 partner sites.

Specializations

Medical Genetics and Rare Inherited Disorders

The investigator applies genomic analysis to hereditary kidney diseases and inherited metabolic disorders, advancing diagnostic precision.

  • Congenital antithrombin deficiency
  • Dominantly inherited Alzheimer disease
  • Monogenic liver fibrosis
  • Rare vasculitides (e.g., ANCA-associated)

These efforts support targeted counseling and personalized therapeutic strategies.

Oncology and Tumor Genomics

Focus lies on molecular profiling of solid tumors such as non‑small cell lung cancer and advanced biliary tract cancers, guiding precision oncology.

  • FGFR‑altered gastrointestinal cancers
  • KRAS G12C‑mutant lung carcinoma
  • Claudin‑18.2 positive pancreatic adenocarcinoma
  • Melanoma with BRAF V600E mutation

Genomic insights inform selection of targeted agents and immunotherapies.

Cardiovascular and Metabolic Diseases

Research addresses risk stratification in atherosclerotic cardiovascular disease and management of chronic kidney disease with high proteinuria.

  • Elevated lipoprotein(a) (Lp(a))
  • Heart failure with reduced ejection fraction
  • Atrial fibrillation in hypertensive patients
  • Obesity‑related metabolic syndrome

Findings aim to reduce cardiovascular events and improve renal outcomes.

Autoimmune and Inflammatory Conditions

The investigator studies immune‑mediated diseases including ANCA‑associated vasculitis and moderate‑to‑severe atopic dermatitis, exploring novel immunomodulators.

  • Systemic lupus erythematosus
  • Rheumatoid arthritis refractory to methotrexate
  • Hidradenitis suppurativa
  • Chronic spontaneous urticaria

These studies seek to improve disease control and quality of life.

Neurological and Neurodegenerative Disorders

Efforts target early detection and therapeutic avenues for Alzheimer disease and multiple sclerosis, integrating biomarker research.

  • Early symptomatic Alzheimer’s disease
  • Progressive primary‑progressive multiple sclerosis
  • Diffuse intrinsic pontine glioma
  • Parkinson’s disease with cognitive decline

Work contributes to disease‑modifying strategies and patient monitoring.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.